Laguna Biotherapeutics Inc. — Form D
Laguna Biotherapeutics Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-28. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-10-28
- Form: D
- Accession: 0001952403-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 2
- Date of first sale: 2022-09-13
- Revenue range: Decline to Disclose
- SEC file number: 021-463089
Issuer
- Name: Laguna Biotherapeutics Inc.
- CIK: 0001952403
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2315 6TH STREET, BERKELEY, CA, 94710
- Phone: (814) 880-6495
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Russell Carrington | Director | Berkeley, CA |
| Jonathan Kotula | Director | Berkeley, CA |
| Daniel Portnoy | Director | Berkeley, CA |
| Russell Carrington | Executive Officer | Berkeley, CA |
| Jonathan Kotula | Executive Officer | Berkeley, CA |
More